Minor triple positive refers to the positive HBsAg, anti-HBe and anti-HBc in the two halves of viral hepatitis B. Patients after combining with fatty liver can be treated with drug therapy, general therapy and surgery.
1. Drug therapy: patients with active replication of hepatitis B virus and fatty liver should choose nucleoside (acid) analogs, such as entecavir, tibivudine, etc., as well as interferon-alpha class, including ordinary interferon and glycol interferon, and at the same time, cooperate with anti-inflammatory and liver-protecting drugs, such as glycyrrhetinic acid preparation, silymarin preparation, etc. The above drugs should be guided by professional physicians. The above drugs should be used under the guidance of specialized physicians.
2. General treatment: it is suitable for patients with inactive hepatitis B virus replication and normal liver function, focusing on changing life habits, formulating reasonable dietary program according to patients’ nutritional status, supplementing protein and vitamin for malnutrition caused by protein deficiency, reducing calorie intake for overweight people, developing good exercise habit, quitting smoking and drinking, and leading a regular life.
3. Surgical treatment: If drug treatment and general treatment are ineffective, or if the patient is seriously ill, liver transplantation can be carried out.
All the above treatments should be chosen under the guidance of doctors.